Abstract: Compositions and methods for preparing nucleic acid nanotubes using DNA origami techniques are described, which provide for nanotubes of predictable and uniform length. The nucleic acid nanotubes thus formed are suitable as liquid crystal preparations enabling liquid-crystal NMR spectroscopy of proteins solubilized in detergent.

Abstract: The invention relates to methods and composition for improving absorption and dissolution of active ingredients of drugs. The invention provides a method of administration of an active ingredient to a mammal through a transmucosal route that includes delivering the active ingredient to a desired site in a body of the mammal, and, sequentially, at the desired site, promoting dissolution and absorption of the active ingredient. In a preferred embodiment, the pH of the localized environment of the active ingredient is sequentially modified to promote dissolution and absorption.

Abstract: Mixed micelles containing poly(L-histidine)-poly(ethylene glycol) block copolymer and poly(L-lactic acid)-poly(ethylene glycol) block copolymer are a pH-sensitive drug carrier that release the drug in an acidic microenvironment, but not in the blood. Since the microenvironment of solid tumors is acidic, these mixed micelles are useful for treating cancer, including those cancers exhibiting multidrug resistance. Targeting ligands, such as folate, can also be attached to the mixed micelles for enhancing drug delivery into cells. Methods of treating a warm-blooded animal with such a drug are disclosed.

Abstract: The present invention relates to improved hair styling compositions and methods of using such compositions. More particularly, the present invention relates to hair styling compositions with improved durability performance of the hair fixative resins, including resistance to high humidity, low tackiness, and good hold.

Abstract: The present invention discloses the autoinducer compounds, such as acyl homoserine lactones, acyl homocysteine lactone, acyl thiolactones, furanones or signal peptides, and their use in animal feed additives and animal feeds to improve animal performance.

Abstract: A nail polish composition comprises a cellulosic filmogenic polymer, a plasticizer and one or more solvents, and is characterized in that it includes 20 to 200% by weight, relative to the cellulosic polymer, of at least one second filmogenic polymer partially insoluble in the cellulosic polymer, giving rise to settling into at least two stable and separate liquid phases at rest. Preferably, the second filmogenic polymer is a vinyl resin, for example polyvinylbutyral. After agitation, this composition has a homogeneous appearance, and can be applied to the nails like a conventional polish.

Abstract: Methods and compositions are described for relieving joint pain and discomfort in a warm-blooded vertebrate by delivering via oral ingestion a nutritional supplement comprising an effective amount of hyaluronic acid, or a salt or digest thereof, and a nutritionally acceptable carrier.

Abstract: The present invention provides a substrate having a plurality of immobilised furanone moieties associated with at least part of a surface of the substrate. The invention also relates to articles consisting of or comprising such a substrate.

Abstract: The present invention relates to pharmaceutical compositions in the form of a gel for controlled- or sustained-release of a pharmaceutically active agent and to methods for treating or preventing or preventing a condition in an animal by administering to an animal in need thereof the pharmaceutical compositions. One particular type of condition for which the pharmaceutical compositions are useful is a microbial infection, e.g., of the skin, ear, or eye, especially for veterinary applications.

Abstract: The present invention relates to plasters for prophylaxis and/or treatment of a dysfunction or disorder of nails, especially onychomycosis, onychocryptosis, nail psoriasis, melanonychia striata, and onychodystrophy, the use of said plasters and methods for prophylaxis and/or treatment of a dysfunction or disorder of nails using said plasters. Said dysfunction or disorder of nails may be induced or caused by drugs, systemic diseases, chemical compounds, physical influences, fungal, yeast, or bacterial infection of the nails and/or the nail beds, or in the context of skin diseases. The plasters show good therapeutically effects on said dysfunction or disorder of nails without the need of drilling a hole into the nail and/or daily scraping of the nail. Preferred embodiments of the plasters consist of an occlusive backing layer and a layer attached to said backing layer. The layer comes in close contact with the nail and optionally with the surrounding skin.

Abstract: Provided herein are ready-to-use premixed pharmaceutical compositions of nicardipine or a pharmaceutically acceptable salt and methods for use in treating cardiovascular and cerebrovascular conditions.

Abstract: The present invention relates to a novel pharmaceutical composition for transdermal or transmucous administration of at least one active substance, and comprising especially a fatty acid as a percutaneous absorption promoter, at least one alcoholic vehicle and also a stabilizer capable of stabilizing the fatty acid in the said pharmaceutical composition.

Abstract: A method of treatment for epilepsy and other disease states is described, which comprises the delivery of gabapentin in a gastric retained dosage form.

Abstract: An aqueous hair conditioning composition comprising discrete, dispersed droplets of a hydrophobic conditioning oil with a mean droplet diameter (D3,2) of 4 micrometers or less, a cationic deposition polymer and a block copolymer of ethylene glycol and propylene glycol according to the Formula (I) with the mean value of y from 10 to 60 and the values of x and z both from 1 to 150, or a block copolymer according to Formula (II) wherein the mean value of a is 2 or more and the mean value of b is 2 or more.

Abstract: The invention relates to a hair cosmetic composition comprising amideamine (I) and aliphatic alcohol (II): wherein R1CO represents aliphatic acid residues among which C20 or more aliphatic acid residues account for 60 wt % or more, preferably 75 wt % or more, C20 aliphatic acid residues account for 3 wt % or more, and C22 aliphatic acid residues account for 50 to 95 wt %, and R2—OH??(II) wherein R2 represents C8 to C30 aliphatic hydrocarbon groups wherein linear aliphatic hydrocarbon groups account for 80 wt % or more to the total aliphatic hydrocarbon groups.

Abstract: A medical device and a method for imparting antibacterial properties to the device, made from hydrophobic polymer, particularly to urinary latex catheters comprises treatment of the device by spreading, dipping or spraying and consequent drying with natural biodegradable polymers (A), composition including a cross-linking agent (B) for partial cross-linking the mentioned polymer and an anti-microbial agent compatible with A and B. The polymer may be from a group of polysachharides, for example polyglucosamine-chitosan. For partial cross-linking of the polymer substances having aldehyde groups such as glucose or evolving aldehydes such as hexamethylenetetramine or their mixtures are used. The polymer is able to form on the surface of the medical device a thin film that swells in wet or moisturized state once inserted into the body. In the swollen state it will gradually release an anti-microbial agent.

Abstract: An electroless method of forming high aspect ratio metal particles includes the steps of mixing a metal or metal salt with at least one acid to form an acidified metal halide salt solution, and mixing the solution with a supersaturated sol to form a sol comprising solution. Metal cations provided by the acidified metal salt are reduced to form a plurality of high aspect ratio metal particles. Instead of using a sol, an organic compound can be oxidized to generate the reducing agent. A metal comprising particle assembly includes a plurality of high aspect ratio metal platelets having an aspect ratio of a major dimension averaging from 10 to 200 times a nanoscale minor dimension of the platelet. The platelets can be used for nail polish, eye liner or the cores for medical delivery vehicles.

Abstract: Agents mimicking DOPAchrome tautomerase activity are administered, notably topically applied, to protect and/or regenerate the melanocytes of hair follicles, to promote the cyclic renewal of the follicular pigmentation unit, to prevent and/or limit and/or arrest the development of canities, and to maintain the natural pigmentation of gray or white head hair and/or body hair.

Abstract: The present invention relates to methods and compositions for the production of scaffolds, such scaffolds to be used for a variety of purposes, including tissue engineering. More specifically, the present invention relates to the use of fused crystals, such as fused salt crystals to form a framework. The methods for producing the scaffolds of this invention improve the porosity, interconnectivity and ease of manufacture as compared to prior art methods.

Abstract: A method of treating gastroesophageal reflux disease (GERD), ulcers of the stomach or duodenum, or Zollinger-Ellison Syndrome in a human, by administering pantoprazole sodium multiparticulates is described. The pantoprazole multiparticulates have a spheroid core of pantoprazole or an enantiomer thereof, or a salt thereof, a surfactant, and a disintegrant; a sub coat which is comprised of hydroxypropyl methylcellulose (hypromellose) and water, an enteric coat on the subcoat, and a final seal coat over the enteric coat, which is composed of hydroxypropyl methylcellulose (hypromellose) and water.